The Prepared Tau Exon-specific Antibodies Revealed Distinct Profiles of Tau in CSF of the Patients with Creutzfeldt-Jakob Disease
Overview
Authors
Affiliations
Background: The diagnostic value of CSF tau for Creutzfeldt-Jakob disease (CJD) has been widely evaluated, showing a markedly disease-relative manner. However, the profiles of tau isoforms in CSF of CJD patients remain unknown. Here, we prepared the exon-specific antibodies against the peptides encoded by exon-2, exon-3 and exon-10 of human tau protein and evaluated the reactive profiles of tau in CSF samples from the patients with probable CJD.
Methodology/principal Findings: Sequences encoding exon-2, exon-3 and exon-10 of human tau protein were cloned into a prokaryotic expression vector pGEX-2T. Using recombinant fusion proteins GST-E2, GST-E3 and GST-E10, three tau exon-specific antibodies were elicited. Reliable specificities of the prepared antibodies were obtained after a serial of purification processes, not only in recognizing the tau peptides encoded by exon-2, -3 and -10, but also in distinguishing six recombinant tau isoforms by Western blot and ELISA. Three predominant tau-specific bands were observed in CSF samples with the exon-specific and the commercial tau antibodies, respectively, showing different reactive profiles between the groups of probable CJD and non-CJD. A 65 KD band was detected only in the CSF samples from probable CJD patients, especially with the antibodies against exon-2 (Anti-tE2) and exon-10 (Anit-tE10). The appearances of 65 KD band in CSF correlated well with positive 14-3-3 in CSF and typical abnormality in EEG. Such band was not observed in the CSF samples of six tested genetic CJD patients.
Conclusions/significance: Three exon-specific polyclonal antibodies were successfully prepared. Based on these antibodies, different CSF tau profiles in Western blots were observed between the groups of probable CJD and non-CJD. A disease-specific tau band emerged in the CSF samples from probable sporadic CJD, which may supply a new biomarker for screening sporadic CJD.
Yadikar H, Torres I, Aiello G, Kurup M, Yang Z, Lin F PLoS One. 2020; 15(7):e0224952.
PMID: 32692785 PMC: 7373298. DOI: 10.1371/journal.pone.0224952.
Chen C, Hu C, Shi Q, Zhou W, Xiao K, Wang Y Front Neurosci. 2019; 13:934.
PMID: 31551692 PMC: 6737049. DOI: 10.3389/fnins.2019.00934.
Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.
Chen C, Xu X, Zhang R, Ma Y, Lv Y, Li J Prion. 2017; 11(5):338-351.
PMID: 28956708 PMC: 5639854. DOI: 10.1080/19336896.2017.1349590.
Chen C, Zhou W, Lv Y, Shi Q, Wang J, Xiao K Mol Neurobiol. 2015; 53(6):3999-4009.
PMID: 26188647 DOI: 10.1007/s12035-015-9348-2.
Chen C, Xiao D, Zhou W, Shi Q, Zhang H, Zhang J Mol Neurobiol. 2013; 49(1):290-302.
PMID: 23912784 DOI: 10.1007/s12035-013-8519-2.